These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2700699)

  • 21. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1212-6. PubMed ID: 2802549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infections.
    Griffiths GK; VandenBurg MJ; Wight LJ; Gudgeon AC; Kelsey M
    Curr Med Res Opin; 1987; 10(8):555-61. PubMed ID: 3677790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In-vitro activity of cefuroxime-axetil against pathogens of bacterial infections of the respiratory tract].
    Kayser FH; Bille J
    Schweiz Rundsch Med Prax; 1990 Nov; 79(45):1383-6. PubMed ID: 2080392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of Cefuroxime axetil in S. typhi.
    Mathur YC; Mathur NC; Lal HM
    Indian Pediatr; 1996 Dec; 33(12):1033-7. PubMed ID: 9141805
    [No Abstract]   [Full Text] [Related]  

  • 25. [A clinical observation of cefuroxime in pediatric field (author's transl)].
    Ohnuma K; Asuka N; Aoyama R; Nagata K
    Jpn J Antibiot; 1979 Nov; 32(11):1117-21. PubMed ID: 41955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of oral cefuroxime axetil into the human aqueous humor.
    Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
    Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral cephalosporins. Role of cefuroxime-axetil].
    Bergogne-Berezin E
    Therapie; 1988; 43 Suppl 4():343-9. PubMed ID: 3065977
    [No Abstract]   [Full Text] [Related]  

  • 28. Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.
    Preston D; Therasse D; Zeckel ML
    J Infect Dis; 1998 Nov; 178(5):1547-9. PubMed ID: 9780287
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of cefuroxime axetil in clinical practice].
    Słowińska M; Szymańska E; Walecka I; Rudnicka L
    Pol Merkur Lekarski; 2000 Nov; 9(53):785-90. PubMed ID: 11204332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
    Gooch WM; Swenson E; Higbee MD; Cocchetto DM; Evans EC
    Clin Ther; 1987; 9(6):670-7. PubMed ID: 3125976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A large scale, general practice based investigation into the clinical efficacy and tolerability of cefuroxime axetil in women with uncomplicated urinary tract infection.
    Bulpitt D; Potter CE; Jaderberg M
    Curr Med Res Opin; 1991; 12(5):318-24. PubMed ID: 2004544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tonsillopharyngitis: evaluation of short-term treatment with cefuroxime axetil versus standard 10-day penicillin V therapy.
    Gehanno P; Chichie D
    Br J Clin Pract; 1995; 49(1):28-32. PubMed ID: 7742180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis.
    Boguniewicz M; Sampson H; Leung SB; Harbeck R; Leung DY
    J Allergy Clin Immunol; 2001 Oct; 108(4):651-2. PubMed ID: 11590398
    [No Abstract]   [Full Text] [Related]  

  • 37. Pefloxacin versus cefuroxime axetil for single-dose therapy of acute uncomplicated lower urinary tract infections in women.
    Krcmery S; Hromec J; Gulla D
    J Chemother; 1995 Nov; 7 Suppl 4():168-9. PubMed ID: 8904145
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
    Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of the tolerance of a new antibiotic by a pharmacovigilance cohort. Apropos of cefuroxime-axetil].
    Carbon C; Bons J; Georges D
    Therapie; 1988; 43 Suppl 4():369-72. PubMed ID: 3222779
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cefuroxime axetil (Zinnat)--laboratory and clinical study].
    Vyhnánek F; Hejzlar M; Procházka M; Pellar T; St'astná L; Silarová J; Kittnar E; Vedral T
    Rozhl Chir; 1990 Oct; 69(10):668-73. PubMed ID: 2263996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.